Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report.

Kyoko Inadomi,Hozumi Kumagai,Shuji Arita,Nobuhiro Tsuruta,Kotoe Takayoshi,Koji Mishima,Shun Ichiro Ota,Mamoru Tanaka,Yuta Okumura,Kosuke Sagara,Kenta Nio,Michitaka Nakano,Hiroshi Uchi,Hidetaka Yamamoto,Hiroshi Ariyama,Hitoshi Kusaba,Hiroaki Niiro,Yoshinao Oda,Koichi Akashi,Eishi Baba

Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report.

2016

AbstractBackground:Anti-programmed cell death 1 antibody nivolumab is a promising agent for various cancers. Immune-related adverse events are recognized; however, bi-cytopenia with nivolumab has not been reported.Case presentation:A 73-year-old man was diagnosed with advanced primary malignant mela

Keywords:

Antibody
Diabetes mellitus
Nivolumab
Melanoma
Esophagus
Medicine
Programmed cell death
Anemia
Adverse effect
Oncology
Internal medicine
anti pd 1
Bi-Cytopenia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations